Israeli medical device company IceCure has developed a new technology called ProSense, which it says has proven extremely effective in treating women with breast cancer, the company said in a press release on Thursday.
ProSense was created to find a non-surgical and less invasive alternative that can destroy tumors using cryotherapy technology.
It utilizes a probe that is inserted into the tumor and freezes it by lowering its temperature, leaving the healthy tissue around it while alternating between freezing and thawing the specific area of the tumor.
The technology has been referred to as a “breakthrough device” by the US Food and Drug Administration (FDA), which officially recognized the innovation last month as having the capabilities to save lives.
Originally posted at vfinews.com